Health
FDA Advisory Panel on Peptide Compounding
An FDA advisory panel is set to debate the regulation of compounding pharmacies offering peptides, a contentious issue with implications for patient safety and market dynamics.
Coverage timeline — 4 articles
STAT News
FDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer bet than the gray-market versions now in use.
2026-07-23 08:30 UTC
STAT News
New maternal billing codes should create a transparent system where both patients and clinicians can thrive, ACOG writes.
2026-07-23 08:30 UTC
STAT News
“This change is likely to lead to only modest increases in total medical expenses. However, it coincides with many other factors raising health insurance premiums,” writes Jeff Levin-Scherz.
2026-07-23 08:30 UTC
STAT News
Veterans who want to rejoin the military are often bogged down in bureaucratic red tape.
2026-07-23 08:30 UTC